Designing targeted therapeutics is critical for effective elimination of cancer cells, and peptide libraries are commonly used to quickly identify important biomarkers on cancer cells. Peptides corresponding to tumor associated antigens (TAA) are displayed in a library format and bioactive peptides are screened. Once identified, highly specific antibodies can be designed for cancer immunotherapy or cancer vaccines.
Design recommendations:
Service | Standard peptide library |
---|---|
Design | Overlapping library design |
Purity | Crude or >70% purity |
Peptide libraries are commonly used to identify immunogenic epitopes and also evaluate vaccine effectiveness. Since libraries can span an entire protein sequence, no important epitopes will be missed. In addition, while vaccines should ideally be tested first, this is not recommended for certain highly infectious diseases (Chen, ACS Chem Biol, 2014). In this case, peptide libraries are ideal for in vitro immune monitoring. To find out more about how peptide libraries accelerate vaccine development, click here.
Design recommendations:
Service | Standard peptide library |
---|---|
Design | Overlapping library or Alanine scanning library |
Purity | High purities recommended (>90%) |
Engineering T cells to target and eliminate viruses and cancer cells has become a very important research field. By engineering the receptor to identify specific TAAs or viral epitopes (Franzoni, Clin Vaccine Immunol, 2013), immunotherapy becomes much more efficient and effective. Chimeric antigen receptor (CAR) T cells are examples of such cells, and peptide libraries are invaluable for identifying the antigenic sequences against which to design the T cell receptor.
Design recommendations:
Service | Micro-scale peptide library or Standard peptide library |
---|---|
Design | Overlapping library design and Truncated library design |
Purity | Crude or >70% purity |
Design details | Overlapping library: 10-15 AA peptides, 2-4 AA overlap |
Truncated library: 8-12 AA peptides |
Identifying the antigens that stimulate antibody and T cell binding is an important first step in immunotherapy development. Potential antigens are sequenced and separated into overlapping peptides. When positive T cell or antibody binding is confirmed, these peptide sequences can then be used to design targeted therapeutics. For more information on how peptide libraries have accelerated antibody and T cell epitope mapping, click here.
Design recommendations:
Service | Standard peptide library |
---|---|
Design |
Overlapping library, positional scanning library, or truncation library design |
Purity | Crude or >70% purity |
Individually aliquoted peptide sequences that comprise a larger protein can be ideal for a variety of biological assays. These libraries can be used to identify peptides that have antimicrobial activity, direct stem cell differentiation, or even monitor pharmacologic activity.
Design recommendations:
Service | |
---|---|
Design | |
Purity | >70% purity or higher |
Picotti P and Aebersold R. Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nature Methods. 2012 May 30;9(6):555-66. doi: 10.1038/nmeth.2015.
Chen G et al. Synthetic antibodies with a human framework that protect mice from lethal Sudan ebolavirus challenge. ACS Chem Biol. 2014 Oct 17;9(10):2263-73. doi: 10.1021/cb5006454.
Franzoni G et al. Assessment of the phenotype and functionality of porcine CD8 T cell responses following vaccination with live attenuated classical swine fever virus (CSFV) and virulent CSFV challenge. Clin Vaccine Immunol. 2013 Oct;20(10):1604-16. doi: 10.1128/CVI.00415-13.